Today on DrugResearcher.com   Eli Lilly opens door for next-generation antipsychotics Entelos snaps up Iconix, adds safety to efficacy prediction Preclinical outsourcing to Asia 'off the horizon' Micromet sticks to tough cancer target Sigma-Aldrich jump on the LentiExpress for RNAi screening

Related Industry News   eClinical news in brief Lonza's China plan taking shape Silicon nanowires conduct drugs into cells EU approval of new Rebif just what the doctor ordered

Breaking News on Drug Discovery
Daily  Monday 03 September 2007		Forward to a colleague

	Product Presentation New Nanoliter Pipetting with an approved Simultaneous Pipettor CyBio has introduced an innovative enhancement in simultaneous pipetting, two new exchangeable modules for Nanoliter parallel pipetting further extending the broad range of applications of the proven CyBio®-Well vario pipetting platform... Click Here Access Full Stories Eli Lilly opens door for next-generation antipsychotics Positive results from a Phase II trial have shown that Eli Lilly's latest antipsychotic drug acts on a new target and avoids key adverse effects caused by other antipsychotics... Read Entelos snaps up Iconix, adds safety to efficacy prediction Entelos has decided to upgrade its computational models that predict drug responses in 'virtual patients' by snapping up a toxicology specialist... Read Preclinical outsourcing to Asia 'off the horizon' A recent survey reveals that Western pharma companies are still shying away from outsourcing preclinical work to Asia. Meanwhile, Covance and Charles River clearly dominate this niche industry sector... Read Micromet sticks to tough cancer target Micromet is sticking to its research into cell adhesion antibodies to treat breast cancer and other tumours, hoping it will have more luck than GlaxoSmithKline and Centocor's failed attempt... Read Sigma-Aldrich jump on the LentiExpress for RNAi screening Sigma-Aldrich has launched a new technology that promises to dramatically simplify and speed-up high-throughput (HT) RNAi screening of the human kinome... Read
	All News Headlines for: September | August | July
	Product Brochure A revolution in Sales Lead Generation! - Free Download Promote your products and technology towards our readers, and we'll build a detailed profile of each person who reads your presentation document... Download our FREE Smart Lead Generation brochure now!... Click Here
	Related Industry News eClinical news in brief Outsourcing-Pharma tracks the latest eClinical movements, featuring Phase Forward, Medidata and ICON... Read Lonza's China plan taking shape Lonza's $200m (€147m) investment in China is continuing to shape up as the firm announced its new small-scale exclusive synthesis manufacturing plant will be up and running next month... Read Silicon nanowires conduct drugs into cells New research has shown that silicon nanowires can be used to deliver toxic agents into both human and bovine epithelial cell lines, opening up new options for drug targeting and delivery... Read EU approval of new Rebif just what the doctor ordered Merck Serono's new and improved version of its blockbuster multiple sclerosis (MS) drug Rebif (interferon beta-1a) has been approved in the EU, providing a little added protection to the company's MS franchise... Read Weekly comment Chinese scientists given freedom to fail As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according to a state media report this week. Read Product Brochure Surface Characterization by Contact Angle From paints and coatings to biotechnology to nanotechnology, contact angle provides a quick, easy and sensitive measure of surface quality and cleanliness in research, QC and process control... Click Here Previous Headlines Charles River, LAB put their faith in Canada Two big players in the early stage contract research organisation (CRO) arena have announced this week they are expanding their preclinical capabilities in Canada as demand for preclinical testing is rising... Read Chinese scientists given freedom to fail As part of a drive towards greater innovation, the Chinese government looks set to introduce new laws giving its domestic scientists freedom to tackle complex scientific problems without fear of failure, according... Read Bigger is better, reveals CRO survey In terms of contract research organisations (CROs), bigger is actually better, reveals a recent Lehman Brothers survey, which offers some fresh insight into this growing industry... Read Drugs moving into the clinic: 26 The latest in a series of periodic roundups of drugs that have moved from preclinical research into clinical testing via the announcement of a Phase I trial or an application for a trial to industry regulators... Read Raising the standard of proteomics data A new series of reporting guidelines have been developed by researchers from the European Molecular Biology Laboratory (EMBL) in an effort to aid proteomics data integration and comparison... Read Product Innovation Alerts - Free of Charge Indicate your research interests and receive alerts on relevant products and market innovations Analysis and instrumentation Assays and screening Cell culture & Equipment Chromatography Compounds and consumables Contract services (outsourcing) Drug discovery Genomics / Proteomics Informatics & IT Lab equipment & consumables Liquid handling and automation Liquid handling and sample preparation Production technologies Separation and purification

	Free Newsletters for Pharmaceuticals Access now !Choose from over 20 industry e-newsletters Access Decision News Media e-newsletters for the food, beverage & nutrition industries, click here
	Forward to a colleague

	To continue to receive this newsletter in your inbox, please add newsletter@DrugResearcher.com to your address book
	Update preferences | Change your email address | Unsubscribe
	Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback
	© 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com